EP1689419 - PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 13.01.2023 Database last updated on 24.08.2024 | Most recent event Tooltip | 13.01.2023 | Change - applicant | 13.01.2023 | Withdrawal of application | published on 15.02.2023 [2023/07] | Applicant(s) | For all designated states Ferring B.V. Polarisavenue 144 2132 JX Hoofddorp / NL | [N/P] |
Former [2014/07] | For all designated states Reprise Biophamaceutics, LLC 120 North Main Street, Suite 400 New York, NY 10956 / US | ||
Former [2011/35] | For all designated states Allergan, Inc. 2525 Dupont Drive Irvine, CA 92612 / US | ||
Former [2008/44] | For all designated states Reprise Biopharmaceutics, LLC 120 North Main Street Suite 400 New York NY 10956 / US | ||
Former [2006/33] | For all designated states Fein, Seymour N. 476 Canoe Hill Road New Canaan, CT 06840 / US | Inventor(s) | 01 /
Fein, Seymour N. 476 Canoe Hill Road New Canaan CT 06840 / US | [2008/44] |
Former [2006/33] | 01 /
see applicant ... | Representative(s) | Prins, Hendrik Willem Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL | [N/P] |
Former [2011/43] | Kupecz, András Ferenc Simmons & Simmons LLP Claude Debussylaan 247 1082 MC Amsterdam / NL | ||
Former [2011/35] | Kupecz, András Ferenc Simmons & Simmons WTC H Tower P.O. Box 79023 1070 NB Amsterdam / NL | ||
Former [2009/28] | Lock, Graham James Fry Heath & Spence LLP The Gables Massetts Road Horley Surrey RH6 7DQ / GB | ||
Former [2009/26] | Lock, Graham James Fry Heath & Spence LLP The Gables Massetts Road Horley Surrey RH6 7DQ / GB | ||
Former [2006/33] | Elsy, David, et al Withers & Rogers LLP Goldings House, 2 Hays Lane London SE1 2HW / GB | Application number, filing date | 03781836.6 | 10.11.2003 | [2006/33] | WO2003US35662 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005046707 | Date: | 26.05.2005 | Language: | EN | [2005/21] | Type: | A1 Application with search report | No.: | EP1689419 | Date: | 16.08.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.05.2005 takes the place of the publication of the European patent application. | [2006/33] | Search report(s) | International search report - published on: | US | 26.05.2005 | (Supplementary) European search report - dispatched on: | EP | 11.12.2008 | Classification | IPC: | A61K38/11, A61P13/00 | [2011/05] | CPC: |
A61K9/2018 (EP);
A61K38/095 (EP);
A61K9/0019 (EP);
A61K9/0056 (EP);
A61P13/00 (EP);
A61P13/02 (EP);
|
Former IPC [2009/02] | A61K38/11 | ||
Former IPC [2006/33] | A61K38/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2006/33] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT NIEDRIGEN DOSEN VON DESMOPRESSIN | [2006/33] | English: | PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN | [2006/33] | French: | COMPOSITIONS PHARMACEUTIQUES COMPORTANT DE LA DESMOPRESSINE FAIBLEMENT DOSEE | [2006/33] | Entry into regional phase | 02.06.2006 | National basic fee paid | 02.06.2006 | Search fee paid | 02.06.2006 | Designation fee(s) paid | 02.06.2006 | Examination fee paid | Examination procedure | 07.06.2005 | Request for preliminary examination filed International Preliminary Examining Authority: US | 29.05.2006 | Amendment by applicant (claims and/or description) | 02.06.2006 | Examination requested [2006/33] | 17.03.2009 | Despatch of a communication from the examining division (Time limit: M04) | 12.06.2009 | Reply to a communication from the examining division | 12.04.2010 | Despatch of a communication from the examining division (Time limit: M04) | 08.07.2010 | Reply to a communication from the examining division | 16.11.2010 | Despatch of a communication from the examining division (Time limit: M02) | 20.12.2010 | Reply to a communication from the examining division | 07.02.2011 | Communication of intention to grant the patent | 06.04.2011 | Fee for grant paid | 06.04.2011 | Fee for publishing/printing paid | 02.01.2023 | Application withdrawn by applicant [2023/07] | Appeal following examination | 30.07.2012 | Appeal received No. J0017/12 | 30.07.2012 | Statement of grounds filed | 13.11.2013 | Result of appeal procedure: allowance of appeal | 05.05.2017 | Appeal received No. J0004/17 | 13.11.2013 | Date of oral proceedings | 27.11.2013 | Minutes of oral proceedings despatched | 16.05.2018 | Date of oral proceedings | 11.06.2018 | Minutes of oral proceedings despatched | Divisional application(s) | EP11000464.5 / EP2322194 | EP11000465.2 / EP2322195 | EP11000466.0 / EP2322196 | EP11000467.8 / EP2322197 | EP11000468.6 / EP2322198 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 17.03.2009 | Fees paid | Renewal fee | 02.06.2006 | Renewal fee patent year 03 | 27.11.2006 | Renewal fee patent year 04 | 27.11.2007 | Renewal fee patent year 05 | 25.11.2008 | Renewal fee patent year 06 | 25.11.2009 | Renewal fee patent year 07 | 24.11.2010 | Renewal fee patent year 08 | 23.11.2011 | Renewal fee patent year 09 | 26.11.2012 | Renewal fee patent year 10 | 27.11.2013 | Renewal fee patent year 11 | 26.11.2014 | Renewal fee patent year 12 | 30.11.2015 | Renewal fee patent year 13 | 28.11.2016 | Renewal fee patent year 14 | 27.11.2017 | Renewal fee patent year 15 | 27.11.2018 | Renewal fee patent year 16 | 27.11.2019 | Renewal fee patent year 17 | 27.11.2020 | Renewal fee patent year 18 | 18.11.2021 | Renewal fee patent year 19 | Penalty fee | Additional fee for renewal fee | 30.11.2022 | 20   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Stay/Interruption | 28.03.2011 | Stay of proceedings | [2011/19] | 28.03.2011 | Stay of proceedings | [2022/43] | 02.01.2023 | Resumption of proceedings | [2022/43] | Documents cited: | Search | [E]WO03094886 (FERRING BV [NL], et al) [E] 1-16 * Examples 1-6, Comparative example 1; page 26, line 1 - page 28, line 2 *; | [E]WO2004041153 (FEIN SEYMOUR H [US]) [E] 1-16* Examples 1-6, Comparative example 1; page 27 - page 28 *; | [X] - AGNOLI G C ET AL, "Low-dose desmopressin infusion: renal action in healthy women in moderate salt retention and depletion, and interactions with prostanoids.", PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, (200210), vol. 67, no. 4, ISSN 0952-3278, pages 263 - 273, XP002505856 [X] 1-4,7-16 * abstract * * page 265, column L, line 10 - line 15 * DOI: http://dx.doi.org/10.1054/PLEF.428 | [X] - GROSSMAN A ET AL, "TWO NEW MODES OF DESMOPRESSIN (DDAVP) ADMINISTRATION", BRITISH MEDICAL JOURNAL, LONDON, GB, (19800517), vol. 280, no. 6225, ISSN 0267-0623, page 1215, XP009003428 [X] 1-16 * the whole document * | [X] - JANKNEGT ET AL, "Oral Desmopressin as a New Treatment Modality for Primary Nocturnal Enuresis in Adolescents and Adults: A Double-Blind, Randomized, Multicenter Study", JOURNAL OF UROLOGY, BALTIMORE, MD, US, (19970201), vol. 157, no. 2, ISSN 0022-5347, pages 513 - 517, XP005573964 [X] 1-16 * abstract * DOI: http://dx.doi.org/10.1016/S0022-5347(01)65190-5 | International search | [Y]US4285858 (CORT JOSEPH H, et al); | [Y]US5500413 (LARSSON KRISTER [SE], et al); | [Y]US5990273 (ANDERSSON LARS HENRIK HARALD [SE], et al); | [Y]US5989835 (DUNLAY R TERRY [US], et al) |